Aardvark Therapeutics, Inc. AARD
Set alert
1.27 USD -0.10 -6.99%
As of Nov 2, 11:32 AM ET
1.25 Day range 1.40
0.93 52-week range 16.60
- YTD
- -90.37%
- 1 year
- -88.17%
- Open
- 1.37
- Prev close
- 1.36
- Mkt cap
- 27.59M
- Vol
- 125.80K
- Avg vol
- 592.00K
- EPS
- -3.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.25
- High
- 1.40
Financial health
Altman Z-Score
-1.67 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -5.0×
FY 2022 5y median -18.9× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 2.7×
FY 2022 5y median -7.2× FY 2025
P/FCF -5.3×
FY 2022 5y median -23.0× FY 2025
EV/EBITDA -4.2×
FY 2022 5y median -19.0× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -18.9%
FY 2022 5y median -4.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -54.0%
FY 2022 5y median 29.2% FY 2025
ROIC -58.6%
FY 2022 5y median -64.2% FY 2025
ROA -49.1%
FY 2022 5y median -58.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -175.3%
FY 2022 FY 2025
EPS (diluted) -177.9%
FY 2022 FY 2025
Free Cash Flow -198.2%
FY 2022 FY 2025
Financial Health
Current Ratio 10.6×
FY 2022 5y median 12.8× FY 2025
Quick Ratio 10.6×
FY 2022 5y median 12.8× FY 2025
Debt / Equity 0.0×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2022 5y median 1.4× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31